Front Row Advisors LLC - ARBUTUS BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$21,315
+88712.5%
10,5000.0%0.01%
-9.1%
Q2 2023$24
-25.0%
10,5000.0%0.01%
-26.7%
Q1 2023$32
+33.3%
10,5000.0%0.02%
+25.0%
Q4 2022$24
-99.9%
10,5000.0%0.01%
+20.0%
Q3 2022$20,000
-28.6%
10,5000.0%0.01%
-28.6%
Q2 2022$28,000
-9.7%
10,5000.0%0.01%
+16.7%
Q1 2022$31,00010,5000.01%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders